All participants | p value | Minimal/mild symptom group | p value | Severe symptom group | p value | |
---|---|---|---|---|---|---|
Comparison, n | 837 | Â | 416 | Â | 421 | Â |
Intervention, n | 834 | Â | 414 | Â | 420 | Â |
Baseline to 6Â months | ||||||
 Mean QALYs (SD) [1] | ||||||
  Comparison | 0.610 (0.281) |  | 0.776 (0.162) |  | 0.445 (0.275) |  |
  Intervention | 0.606 (0.285) |  | 0.776 (0.163) |  | 0.439 (0.282) |  |
Mean difference, Coef. (95% CI) | ||||||
 Primary analysis [2] | -0.004 (-0.024 to 0.017) | .733 | -0.004 (-0.025to 0.018) | .737 | -0.002 (-0.036 to 0.033) | .922 |
 Sensitivity analysis [3] | -0.002 (-0.027 to 0.023) | .883 | 0.000 (-0.026 to 0.025) | .991 | -0.002 (-0.044 to 0.040) | .927 |
 Sensitivity analysis [4] | -0.002 (-0.026 to 0.023) | .901 | 0.001 (-0.025 to 0.026) | .967 | -0.002 (-0.044 to 0.040) | .931 |
 Sensitivity analysis [5] | 0.004 (-0.010 to 0.017) | .620 | -0.001 (-0.016 to 0.013) | .840 | 0.009 (-0.013 to 0.031) | .407 |
 Sensitivity analysis [6] | -0.002 (-0.018 to 0.013) | .782 | 0.000 (-0.015 to 0.012) | .900 | -0.001 (-0.029 to 0.026) | .926 |
Baseline to 12Â months | ||||||
 Mean QALYs (SD) [1] | ||||||
  Comparison | 0.621 (0.287) |  | 0.779 (0.173) |  | 0.465 (0.287) |  |
  Intervention | 0.613 (0.282) |  | 0.772 (0.166) |  | 0.456 (0.294) |  |
Mean difference, Coef. (95% CI) | ||||||
 Primary analysis [2] | -0.008 (-0.029 to 0.014) | .481 | -0.001 (-0.033 to 0.013) | .400 | -0.004(-0.041 to 0.033) | .831 |
 Sensitivity analysis [3] | -0.002 (-0.027 to 0.023) | .883 | -0.000 (-0.026 to 0.025) | .991 | -0.002 (-0.044 to 0.040) | .927 |
 Sensitivity analysis [4] | -0.002 (-0.026 to 0.023) | .901 | 0.001 (-0.025 to 0.026) | .967 | -0.002 (-0.044 to 0.040) | .931 |
 Sensitivity analysis [5] | 0.004 (-0.010 to 0.017) | .620 | -0.001 (-0.016 to 0.013) | .840 | 0.009 (-0.013 to 0.031) | .407 |
 Sensitivity analysis [6] | -0.006 (-0.022 to 0.011) | .506 | -0.006 (-0.020 to 0.008) | .414 | -0.003 (-0.033 to 0.026) | .827 |